Work

Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis

Year: 2021

Type: article

Source: International Journal of Pharmaceutics

DOI: 10.1016/j.ijpharm.2021.121369

Authors: Wagdy M. Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Fatma Al-Zahraa Sayed, Mohamed Fares, Sara T. Al-Rashood, Zainab M. Elsayed, Marwa M. Abdel-Aziz, Eslam B. Elkaeed, Mahmoud Elsabahy, Noura G. Eissa

Institutions: Kafrelsheikh University, King Salman International University, Badr University in Cairo, The University of Sydney, King Saud University, Al-Azhar University, Almaarefa University, Texas A&M University, Zagazig University

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: King Saud University

Award: G8757880413

OpenAlex ID: W4200469356

FWCI: 1.268

Cites: 44

Cited by: 28

Related to: 10